Related references
Note: Only part of the references are listed.Identification of ITK deficiency as a novel genetic cause of idiopathic CD4+ T-cell lymphopenia
Nina Kathrin Serwas et al.
BLOOD (2014)
Hematopoietic stem cell, transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders
Oded Shamriz et al.
CLINICAL IMMUNOLOGY (2014)
Interleukin-2-Inducible T-Cell Kinase (ITK) Deficiency - Clinical and Molecular Aspects
Sujal Ghosh et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Severe EBV hepatitis treated with valganciclovir
R. Pisapia et al.
INFECTION (2013)
IL-2-Inducible T-Cell Kinase Deficiency with Pulmonary Manifestations due to Disseminated Epstein-Barr Virus Infection
D. Mansouri et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases
R. M. Linka et al.
LEUKEMIA (2012)
IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach
Polina Stepensky et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Valacyclovir Pharmacokinetics and Exploratory Pharmacodynamics in Young Adults With Epstein-Barr Virus Infectious Mononucleosis
Heather E. Vezina et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation
Kirsten Huck et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Share Paper
